Heba Degheidy, M.D., Ph.D., a post-doctoral research fellow at FDA, stores stem cell samples for analysis in an FDA laboratory on the National Institutes of Health (NIH) campus in Bethesda, Md.

Steven R. Bauer, Ph.D., chief of the Cellular and Tissue Therapy Branch in FDAs Office of Cellular Tissue and Gene Therapies (standing), visits his team of scientists in their lab.

For more photos of FDA's stem cell research team at work go to Flickr.

Get Consumer Updates by E-mail

Consumer Updates RSS Feed

Print & Share (PDF 308 K)

On this page:

Scientists sporting white coats and safety gloves are working in a bright Food and Drug Administration (FDA) lab on an incredible project.

They are part of FDAs MSC Consortium, a large team of FDA scientists studying adult mesenchymal stem cells (MSCs)cells that could eventually be used to repair, replace, restore or regenerate cells in the body, including those needed for heart and bone repair.

The scientistsinvestigational work is unprecedented: Seven labs at FDA's Center for Biologics Evaluation and Research formed the consortium to fill in gaps in knowledge about how stem cells function.

Link:
Adult Stem Cell Research Shows Promise